Weight Reduction ￥1980/Pen

Ozempic(Wegovy) is a GLP-1 receptor agonist that mimics the action of glucagon-like peptide-1 (GLP-1), delaying gastric emptying, suppressing appetite via the central nervous system, and enhancing satiety. It also regulates insulin and glucagon secretion to improve glucose and lipid metabolism

Weight Loss Efficacy

· Clinical Trials: In the STEP trials, participants achieved an average weight reduction of 13.7%-15%, with some losing over 40% of body weight. Usually most customers reduced 3-5kg after 1 pen.

· Real-World Data: Users reported reduced appetite and gradual weight loss (e.g., from 83.25kg to 75.3kg), though individual responses vary

Advantages Over Other Methods

· Diet/Exercise: Offers more stable results by physiological appetite suppression, unlike traditional methods reliant on willpower.

· Bariatric Surgery: Non-invasive with lower complication risks.

· Other Drugs: While tirzepatide (Zepbound) shows higher efficacy (20.2% vs. 13.7%), Ozempic(Wegovy) has earlier approval and extensive clinical validation.

Ideal For

· Individuals with BMI≥27 plus obesity-related comorbidities (e.g., diabetes) or BMI≥30.

Contraindications

· History of medullary thyroid carcinoma or familial predisposition;

· Pancreatitis, severe gastrointestinal disorders;

· Pregnancy and lactation

Long-Term Maintenance Tips

· Continuous Use Required: Discontinuation may lead to weight regain; lifestyle modifications are crucia. You need to formulate a new lifestyle for eating.If you keep overeating, of course, you gain weight again. but if you take this chance to.Build up a new diet. Yes, of course you will keep your weight for a long time

· Sustainability: Long-term use can maintain weight loss but requires protein-rich diets to counteract muscle loss